next generation glp-1 Revolutionizing obesity treatment: The emerging role of receptor agonists and next-generation pharmacotherapies What's Coming Next for GLP-1

Even if the supply constraints are resolved, that doesn't impact the affordability issues with branded weight loss drugs, he added

Macromol Biosci

On average, GLP-1s can lead to 15% or more body weight reduction, and for those who have lived with obesity for years, their lives will change dramatically. Tran says using GLP-1s can lead to less spending on food, with users eating smaller portions, cutting unnecessary snacking, finding fast food less appealing, and experiencing reduced cravings for high-sugar foods

The Wegovy pill is FDA-approved for: Weight loss in adults with obesity or overweight with at least one weight-related health condition (such as type 2 diabetes or obstructive sleep apnea) in adults with heart disease and obesity or overweight Cardiovascular risk reduction Like Rybelsus, Wegovy follows a dosage titration schedule

It is unclear whether the people in the study were prescribed the medication for diabetes or obesity

For many patients, transitioning to a maintenance dose after achieving weight loss may be a practical and sustainable long-term strategy. Weight loss surgery vs